PHI 27 (human) trifluoroacetate

PHI 27 (human) trifluoroacetate is a synthetic peptide corresponding to the human Peptide Histidine Isoleucine-27, widely recognized for its role in modulating neuroendocrine and gastrointestinal functions. As a chemically synthesized form, it offers high consistency and reliability for research applications involving peptide signaling pathways. The trifluoroacetate salt form ensures enhanced stability and solubility, facilitating its integration into a variety of experimental systems. Researchers value PHI 27 for its ability to mimic endogenous peptide activity, making it a preferred tool in studies aiming to unravel the complexities of peptide-mediated signaling in human physiology. Its structural fidelity to the native human sequence allows for accurate modeling of biological processes, supporting advanced investigations into peptide-receptor interactions and downstream effects.

Neuroendocrine Research: PHI 27 peptide is extensively utilized in neuroendocrine research, where it serves as a model compound to elucidate the mechanisms of peptide signaling within the central and peripheral nervous systems. By acting on specific G-protein coupled receptors, it enables scientists to dissect the pathways governing hormone release, neuronal communication, and feedback regulation in neuroendocrine tissues. The use of this peptide in in vitro and ex vivo systems allows for the controlled study of its effects on neurotransmitter modulation, offering insights into the physiological roles of endogenous PHI peptides in neural regulation and homeostasis.

Gastrointestinal Motility Studies: In gastrointestinal research, PHI 27 (human) trifluoroacetate is employed to investigate its influence on smooth muscle contractility and gut motility. Scientists often incorporate the peptide into organ bath assays or tissue preparations to observe its modulatory effects on intestinal movement and secretion. These studies are instrumental in understanding the physiological regulation of digestive processes and the potential interplay between neuropeptides and enteric nervous system function. By providing a reliable means to simulate endogenous peptide activity, PHI 27 supports the development of new hypotheses regarding gut-brain communication and the regulation of gastrointestinal health.

Signal Transduction Analysis: Researchers utilize PHI 27 to probe signal transduction pathways associated with peptide receptors. By applying the peptide to cultured cells or tissue slices, it is possible to monitor changes in intracellular second messengers, such as cyclic AMP or calcium ions, following receptor activation. This approach helps delineate the molecular mechanisms underlying receptor specificity, desensitization, and downstream signaling events. The ability of PHI 27 to selectively activate its cognate receptors makes it a valuable tool for mapping complex signaling networks and for identifying potential targets for pharmacological modulation.

Receptor Binding Studies: The trifluoroacetate salt of PHI 27 is frequently used in receptor binding assays to determine the affinity and selectivity of peptide ligands for their corresponding receptors. By labeling the peptide or using competitive binding techniques, scientists can quantify receptor-ligand interactions and characterize the pharmacological profile of novel compounds. These studies are critical for advancing the understanding of peptide receptor biology and for guiding the rational design of receptor-targeted molecules in basic research settings.

Peptide Structure-Function Relationship: Investigations into the structure-function relationship of bioactive peptides often incorporate PHI 27 as a reference compound. By comparing the biological activity of native and modified peptide sequences, researchers can identify key structural motifs responsible for receptor activation and biological efficacy. Such studies contribute to the broader field of peptide engineering, informing the design of analogs with enhanced stability, selectivity, or functional properties. The use of PHI 27 in these comparative analyses supports the exploration of structure-activity relationships and the development of innovative peptide-based research tools.

In summary, PHI 27 (human) trifluoroacetate stands as a versatile and scientifically invaluable peptide for advancing research in neuroendocrine signaling, gastrointestinal physiology, receptor pharmacology, and peptide structure-function analysis. Its consistent performance and close resemblance to endogenous human peptides make it an essential component in experimental protocols aimed at deciphering the intricate roles of bioactive peptides in human health and disease. As research continues to uncover new aspects of peptide-mediated regulation, the applications of PHI 27 are poised to expand, supporting innovative discoveries across multiple domains of biomedical science.

1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

2. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

4. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

5. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs